Videos and Podcasts
Pharmaxis Hails Positive Results in Phase 1 Scarring Trial
Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news its novel topical drug treatment for scarring has delivered positive phase 1 clinical trial results and will now advance to the next stage of development in patients with established scars.
Watch the interview here.
Pharmaxis Quarterly Shareholder Update and Investor Presentation
Watch a recording of the Pharmaxis Ltd June Quarterly Shareholder Update by the chief executive officer Mr Gary Phillips on Thursday 29 July 2021.
Watch recording here.
Emerald Financial Small Caps Watch Interview with CEO Gary Phillips
In an interview with Emerald Financial Small Caps Watch, CEO Gary Phillips explains how the company’s lead drug discovery PXS-5505 is being applied to tackle cancer and the keen interest being shown by scientific and global opinion leaders in the progress of clinical work the company is conducting. Watch the interview here:
